This review has identified many studies which demonstrate the substantial efficacy of IWMPs and GLP-1 RAs in treating and managing individuals living with obesity and metabolic disorders across varied demographic and clinical settings, and suggestions of some promising outcomes from GLP-1RAs for women with PCOS. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.